These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33751658)

  • 1. Correlation between cerebral blood flow and olfactory function in mild cognitive impairment and Alzheimer's disease.
    Kashibayashi T; Takahashi R; Fujita J; Fujito R; Kamimura N; Okutani F; Kazui H
    Int J Geriatr Psychiatry; 2021 Jul; 36(7):1103-1109. PubMed ID: 33751658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between regional brain volume and olfactory function in very mild amnestic patients.
    Kashibayashi T; Takahashi R; Fujita J; Kamimura N; Okutani F; Kazui H
    J Neurol Sci; 2020 Apr; 411():116686. PubMed ID: 31972350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Smell Identification Deficit with Alzheimer's Disease Assessment Scale-Cognitive Subscale, Japanese Version Scores and Brain Atrophy in Patients with Dementia.
    Yoshii F; Onaka H; Kohara S; Ryo M; Takahashi W
    Eur Neurol; 2019; 81(3-4):145-151. PubMed ID: 31242486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.
    Takahashi M; Oda Y; Okubo T; Shirayama Y
    J Neural Transm (Vienna); 2017 Sep; 124(9):1109-1121. PubMed ID: 28509077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Odor Discrimination as a Marker of Early Alzheimer's Disease.
    Audronyte E; Pakulaite-Kazliene G; Sutnikiene V; Kaubrys G
    J Alzheimers Dis; 2023; 94(3):1169-1178. PubMed ID: 37355894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer's Disease Spectrum.
    Wang Q; Chen B; Zhong X; Zhou H; Zhang M; Mai N; Wu Z; Huang X; Haehner A; Chen X; Auber LA; Peng Q; Hummel T; Ning Y
    J Alzheimers Dis; 2021; 79(2):585-595. PubMed ID: 33361601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
    Park SJ; Lee JE; Lee KS; Kim JS
    Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory function changes and the predictive performance of the Chinese Smell Identification Test in patients with mild cognitive impairment and Alzheimer's disease.
    Mi Y; Ma X; Du S; Du C; Li X; Tan H; Zhang J; Zhang Q; Shi W; Zhang G; Tian Y
    Front Aging Neurosci; 2023; 15():1068708. PubMed ID: 36861124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine.
    Shirayama Y; Takahashi M; Oda Y; Yoshino K; Sato K; Okubo T; Iyo M
    Brain Imaging Behav; 2019 Feb; 13(1):75-86. PubMed ID: 29247294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regression analysis of cerebral blood perfusion and cognitive function in patients with mild cognitive impairment and Alzheimer's disease].
    Xu Y; Chen LL; Su Y; Sun SN; Zhang HY
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):193-197. PubMed ID: 30669762
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease.
    Yoshii F; Kawaguchi C; Kohara S; Shimizu M; Onaka H; Ryo M; Takahashi W
    Neurol Sci; 2018 May; 39(5):909-918. PubMed ID: 29508099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
    Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
    J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the utility of everyday memory test and the Alzheimer's Disease Assessment Scale-Cognitive part for evaluation of mild cognitive impairment and very mild Alzheimer's disease.
    Adachi H; Shinagawa S; Komori K; Toyota Y; Mori T; Matsumoto T; Sonobe N; Kashibayashi T; Ishikawa T; Fukuhara R; Ikeda M
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):148-53. PubMed ID: 23581865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
    Zainal NH; Silva E; Lim LL; Kandiah N
    Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.
    Devanand DP; Liu X; Chunga RE; Cohen H; Andrews H; Schofield PW; Stern Y; Huey ED; Choi J; Pelton GH
    J Alzheimers Dis; 2020; 75(3):845-854. PubMed ID: 32333591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of olfactory and gustatory disorders in Alzheimer's disease.
    Kouzuki M; Suzuki T; Nagano M; Nakamura S; Katsumata Y; Takamura A; Urakami K
    Neurol Sci; 2018 Feb; 39(2):321-328. PubMed ID: 29128987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.